Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial
Aleix Prat, Cristina Saura, ; TomásPascual, ; Cristina Hernando, ; Montserrat Muñoz, ; Laia Paré;Blanca González, Pedro L Fernandez,; Patricia Galván, Nuria Chic, Xavier Gonzalez- Farré,Mafalda Oliveira, MiguelGil Gil, ; Miriam Arumi, Neus Ferrer, Alvaro Montaño, Yann Izarzugaza, Antonio Llombart-Cussac, Raquel Bratos, Santiago Gonzalez, Eduardo Martínez,Sergio Hoyos, Beatriz Rojas, Juan A Virizuela, Vanesa Ortega,Rafael Lopez, Pamela Celiz,Eva Ciruelos, Patricia Villagrasa, Joaquín Gavilá,
Manuscrito
THE LANCET
2019
CORALLEEN
